9/12 5:30 pm - 8:30 pm
HBA presents 'Putting Academia-Industry Research Partnerships to Work.' Novartis, 1 Health Plaza, East Hanover, NJ more
9/24 4:00 pm - 6:00 pm
CURE presents healthcare investment banker Anthony Gibney of Leerink Swann. Yale Anlyan Center, 300 Cedar Street, New Haven more
10/1 4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Trevi Therapeutics. Anlyan Center, 300 Cedar Street, New Haven. Watch for details.
10/8-9 12th annual BIO Investor Forum. The Palace Hotel, San Francisco more
10/15 6:00 pm - 9:30 pm
HBA presents Women's Healthcare Innovation and Leadership Showcase. Sanofi Campus, 55 Corporate Drive Auditorium, Bridgewater, NJ more
11/7 10:00 am - 3:00 pm
CT Innovation Summit. Mentor meetings, awards ceremony, and more. Co-sponsored by CURE. Oakdale Theater, Wallingford more
11/11-13 The BIO Convention in China. National Convention Center, Beijing more
12/3 5:45 pm - 7:30 pm
CURE Holiday Party. 'The best networking in town.' Café George, 300 George Street, New Haven. Save the Date!

Cost-saving discounts for CURE members!
CURE members can now receive discounts on various products and services, such as lab supplies, shipping services, and gases more

Purdue Pharma L.P.
One Stamford Forum
Stamford, CT 06901-8850

Phone: 203-588-8000
Fax: 203-588-5088
Website: http://www.purduepharma.com

Jim Heins, Associate Director

General Information
Purdue Pharma L.P. is dedicated to serving the evolving needs of healthcare providers, patients and caregivers with innovative prescription and non-prescription medicines. Known for its pioneering research on persistent pain, Purdue has also applied its expertise to other therapeutic areas such as respiratory diseases and bacterial infections and to a growing line of OTC products including laxatives, microbicides and nutraceuticals. A commitment to innovation and caring spans every aspect of the organization, from discovering and launching new medicines to demonstrating their medical value.

Research Activities
Scientific research is at the heart of Purdue. There are three research facilities in the US. Our discovery research scientists in Cranbury, New Jersey are exploring the frontiers of biotechnology to discover novel analgesics and new weapons against cancer, as well as novel treatments for neurological and psychiatric disorders such as neuropathic pain, migraine and insomnia. In Ardsley, New York, our pre- clinical development group is developing novel formulations and drug delivery systems for our growing portfolio of new drug candidates. In Stamford, CT our clinical research and development and regulatory teams design and direct clinical studies to bring our products through rapid evaluation and approval.

Purdue produces a range of differentiated products, including OxyContin? (oxycodone HCl) and MS Contin? (morphine sulfate) for moderate to severe pain, Uniphyl? (theophylline, anhydrous) for asthma, Chirocaine? (levobupivacaine injection) anesthetic, and the popular over-the-counter Senokot? laxatives and Betadine? antiseptics.
Purdue Pharma is part of an international group of associated companies - including Mundipharma in Germany and Napp Pharmaceutical Group in the U.K. - employing more than 5,000 people in pharmaceutical research, manufacturing, sales and marketing worldwide.

Other Information
Ownership: Private
CT Employees: 3,200
World Employees: 5000